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S u m m a r y  
 
I n t r o d u c t i o n .  Melanoma is one of the most 
malignant cancers; however, melanoma in children is a very 
rare disease, accounting for only 1% of all new cases of 
cancer diagnosed annually. The objective of this paper is to 
present two cases of pediatric melanoma malignum with 
respect to model of surgical management related to stage of 
the disease with  surgical approach based on current 
guidelines of American Joint Committee on Cancer (AJCC).  
C a s e  r e p o r t s .  In first case of 4-year old girl, the 
melanotic lesion was on the right arm and sentinel lymph 
node in in right axillary region. After sentinel lymph node 
biopsy (SLNB) of right axillary space and histologic 
diagnosis of confirmed malignancy, the patient was qualified 
for regional lymphadenectomy. The final staging was IIIC 
grade, and further therapy with interferon was continued. In 
the second case of 17-year old boy, with congenital naevus 
on the right earlobe, a SLNB of the right axillary lymph node 
was performed. Histologic examination of the lymph node 
did not reveal metastasis to the lymph node. The final was 
grade IIA and no further therapy was required.  
C o n c l u s i o n s .  Both patients remain in complete 
clinical remission for 9 and 12 months after the diagnosis, 
confirmed by imaging and laboratory examinations. Both 
cases underline proper therapeutic approach based on 
radicalization of surgical treatment, sentinel lymph node 
biopsy followed by regional lymphadenectomy and 
interferon therapy in case of confirmed metastasis or no 




S t r e s z c z e n i e  
 
W s t ę p .  Czerniak złośliwy skóry to jeden z najbardziej 
złośliwych nowotworów, jednak jednocześnie bardzo rzadko 
występujący u dzieci. Jego częstość występowania nie 
przekracza 1% wszystkich przypadków nowotworów 
złośliwych u dzieci. Celem tej pracy jest przedstawienie 
opisu dwóch przypadków czerniaka złośliwego u dzieci  
z podkreśleniem dwóch modeli postępowania chirurgicznego 
w zależności od stopnia zaawansowania nowotworu  
w oparciu o wytyczne American Joint Committee on Cancer 
(AJCC).  
O p i s y  p r z y p a d k ó w .  W pierwszym przypadku 
 4-letniej dziewczynki, zmiana była zlokalizowana na 
ramieniu, a węzeł chłonny wartowniczy w dole pachowym. 
Po wykonaniu biopsji chirurgicznej węzła wartowniczego  
w badaniu histo-patologicznym potwierdzono przerzut,  
w związku z czym wykonano zabieg limfadenektomii 
regionalnej. Po ustaleniu stopnia zaawansowania IIIC, 
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pacjentkę zakwalifikowano do terapii interferonem.  
W drugim przypadku, chłopca 17-letniego, z pierwotną 
zmianą na płatku ucha, wykonano biopsję węzła 
wartowniczego, jednak nie potwierdzono przerzutu do tego 
węzła. W związku z tym ostateczny stopień zaawansowania 
klinicznego ustalony jako IIB oznaczał zakończenie terapii.  
W n i o s k i .  W obydwu przypadkach pacjenci pozostają 
w całkowitej remisji przez okres odpowiednio 12 i 9 miesię-
cy, potwierdzonej w badaniach obrazowych i laborato-
ryjnych. Obydwa przypadki pokazują prawidłowe postępo-
wanie terapeutyczne, oparte na radykalizacji leczenia 
chirurgicznego, biopsji chirurgicznej węzła wartowniczego  
i następowej limfadenektomii regionalnej oraz terapii 
onkologicznej z zastosowaniem interferonu w przypadku 
potwierdzenia przerzutów do węzła albo zakończeniu terapii 
w przypadku nieobecności przerzutów. 
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Melanoma in children is a very rare disease. 
Melanoma accounts for <3% of all cancers seen in 
children, and the incidence in children and adolescents 
accounts for only approximately 1% of all new cases of 
cancer diagnosed annually [1]. The incidence of 
melanoma increases with the advancing age, and is 
very rare in patients younger than 15 years of age 
compared with those between 15-19 years. An overall 
pediatric melanoma incidence is 4.9 per 1 million 
individuals. The annual percentage change of 2.8% 
makes melanoma one of only a few pediatric 
neoplasms with significantly increased rates during last 
two decades [2]. 
The risk factors for melanoma include inherent 
(intrinsic) and acquired (extrinsic) factors. Examples of 
inherent risk factors include age, pigmentation, nevi 
pattern, genetics and family history, and coincident 
medical conditions [3]. A systematic meta-analysis of 
observational studies of melanoma risk factors 
identified an increased melanoma risk for physical 
attributes such as blue eye color, fair skin color, red 
hair color, and high density of freckles [4]. Extrinsic 
factors that contribute to increased melanoma risk 
include sunburns or exposures to medications, such as 
psoralens, which can artificially increase damage 
caused by UV rays. A number of common phototoxic 
medications, such as tetracycline antibiotics, cetirizine, 
propranolol, naproxen, and fluoxetine, lead to 
increased UV damage and sunburns. Also, long-term 
use of medications that cause immune system 
suppression can increase melanoma risk among organ 
transplantation recipients [5]. Chronic systemic 
antifungal prophylaxis with voriconazole, which 
causes photosensitivity, can be associated with 
melanoma [6]. 
The most important and visible pre-melanotic 
feature are the nevi. Congenital nevi are traditionally 
defined as melanocytic nevi  that  are  present  at  birth, 
 
 
and have historically been classified based on final, 
adult size [7]. Categorization of cutaneous features of 
congenital melanocytic nevi include division of 
medium (M1: 1.5–10 cm, M2: >10–20 cm), large (L1: 
>20–30 cm, L2: >30–40 cm), and giant (G1: >40–60 
cm, G2: >60 cm) sized nevi [7]. Most patients (>80%) 
present with localized disease at diagnosis; the 
remainder either have regional lymph node disease 
(10% to 15%) or distant metastasis (1% to 3%) [1]. 
This corresponds to staging of melanoma, including 
stages I and II which are localized melanoma, stage III 
is regional metastasis, and stage IV is distant 
metastasis. 
 
In a patient with ‘signature nevus’ pattern, a nevus 
should be typically evaluated by examination of 
clinical features, including the classic ‘ABCDE’ 
criteria (asymmetry, border irregularity, color 
variegation, diameter >6 mm, and/or evolution), 
known also as Friedman clinical rating, as well as 
pediatric-specific melanoma criteria of melanosis, 
bleeding, ‘bumps’, color uniformity, diameter 
variability, and de novo development [8]. 
Melanoma is one of the most malignant cancers. 
The suspicion is made clinically with dermatoscopy 
and the final diagnosis is made by the histopathological 
examination. The management of patients with 
melanoma is stage-dependent. Proper staging requires 
a thorough clinical, histopathologic, laboratory, 
imaging evaluation and the initial surgical evaluation. 
Pathological changes are classified also according to 
Breslow thickness [12]. 
The objective of this paper is to present two cases 
of pediatric melanoma malignum with respect to a 
model of surgical management related to stage of the 
disease. This surgical approach was based on current 
guidelines of American Joint Committee on Cancer 
(AJCC) [9].  
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CASE REPORT 1 
 
A 4 year old girl, with normal development, was 
admitted to the Department due to naevus on the right 
arm, with recurrent bleeding and increasing size over 
the period of previous six months. Family history was 
without cases of melanoma. The naevus was resected 
with safety margin within unchanged tissue. The initial 
histological diagnosis was melanocytic tumor of 
uncertain malignant potential (MELTUMP) - atypical 
Spitz tumor. The histologic diagnosis was verified in 
reference center (The Children’s Memorial Health 
Institute, Warsaw) and the final diagnosis was 
compound naevus Spitz with focal transformation of 
melanoma malignum (Spitz-like melanoma). The 
lymph node in right axilla region was palpable. 
Ultrasound examination of this area showed enlarged 
hypoechogenic lymph node of size 12 x 11 mm. PET-
CT showed increased metabolism of the lymph node, 
typical for malignancy. No other suspicious foci were 
found by PET scan. The child was qualified for 
radicalization of surgery at the primary site, with 
respective margin of 3.5-4 cm in normal tissues (skin, 
subcutaneous tissue and muscular fascia), followed by 
transplantation of skin from right groin, together with 
sentinel lymph node biopsy (SLNB) of right axillary 
space. Histologic diagnosis of the resected specimen 
confirmed radical excision of the malignant infiltration 
in the previous scar. Also the lymph node pathologic 
examination confirmed metastasis of Spitz-like 
melanoma. According to AJCC guidelines [9], the 
patient was qualified for further radical surgery i.e. 
regional lymphadenectomy. The final clinical AJCC 
staging was grade IIIC, and further conservative 
therapy with interferon alpha-2b for 48 weeks (EST 
protocol). The girl remains in complete clinical 
remission for one year after the diagnosis, confirmed 
by CT and ultrasound examinations.  
 
CASE REPORT 2 
 
A 17-year old boy, with congenital naevus of 8 mm 
diameter localized on right earlobe, without oncologic 
suspicion, was admitted to the Regional Pediatric 
Surgery Department due to mechanical injury of right 
auricle. Family history was without cases of 
melanoma. The initial histological diagnosis of the 
resected naevus was: melanoma malignum, naevoid 
melanoma typus epithelioides exulcerans Clark III, 
Breslow 4 mm. The histologic diagnosis was verified 
in reference center (The Children’s Memorial Health 
Institute, Warsaw) and the final diagnosis was: nodular 
malignant melanoma Clark III, Breslow 4 mm. There 
was no malignant invasion in the epithelium. The small 
lymph node in right axilla region was palpable. 
Ultrasound examination of this area showed enlarged 
hypoechogenic lymph node of size 8 x 5 mm. PET-CT 
showed neither increased metabolism of the lymph 
node nor other suspicious foci. The boy was qualified 
for radicalization of surgical treatment in the area of 
the primary lesion with concurrent plastic surgery of 
the right auricle (Figure 1) together with sentinel 
lymph node biopsy of right axillary space. Histologic 
examination of the lymph node indicated no metastasis 
to the sentinel lymph node. The final clinical AJCC 
staging was grade IIA (T3, N0, M0). The boy remains 
in complete clinical remission for nine months after the 




Fig. 1. Radicalization of the local surgical treatment. Plastic 
surgery of the right auricle 
Ryc. 1. Radykalizacja miejscowego leczenia chirurgicznego. 




In this report we present two cases of very rare 
pediatric melanoma. The diagnosis in both cases was 
confirmed in reference pathology center. In both cases, 
sentinel lymph node biopsy was clinically present. In 
first case, of 4-year old girl, the primary melanotic 
change was oncologically active (increase of naevus 
diameter and bleeding) and PET scan showed 
increased metabolic activity of sentinel lymph node. In 
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second case, of 17-year old boy, the primary melanotic 
change was oncologically inactive and PET scan did 
not show increased metabolic activity of sentinel 
lymph node. In first case radical regional 
lymphadenectomy was performed, while in the second 
one it was not required. Further clinical management 
and follow-up for 9-12 months confirmed proper 
surgical and oncological approach. 
Resection of melanotic change and sentinel lymph 
node should be performed by a trained surgical 
oncologist. Lesions should be primarily excised in such 
a way that the depth of the lesion can be adequately 
assessed, usually with the margin of 1-3 mm. 
Exceptions from this rule include lentigo maligna 
melanoma. Histologic diagnosis of melanoma, with the 
presence or absence of ulceration, thickness of the 
lesion, mitotic rate and assessment of the surgical 
margins will determine the need for further surgery to 
achieve an adequate surgical margin and the need for 
nodal staging. 
Previous studies have reported that compared with 
adults, pediatric melanoma patients exhibit higher rates 
of lymph node metastases ranging from 25 to 40% 
[10]. Although higher rates of lymph node metastases 
have been reported in pediatric melanoma patients, the 
prognostic value of sentinel lymph node biopsy 
(SLNB) has not been extensively studied in this 
population. The few studies on SLNB for pediatric 
melanoma have reported varying results, with some 
studies reporting no recurrences or deaths in positive 
SLNB patients while one study showed that the overall 
survival rate of 94% seen in pediatric melanoma 
patients dropped to 79 % in positive SLNB patients 
[10,11]. Currently, there is a common agreement that 
pediatric patients with clinically localized melanomas 
>1 mm thickness should be offered SLNB. Also, after 
clinical diagnosis the melanoma should be resected 
with one to two centimeter safety margins [12]. 
Nowadays, it seems that patient and tumor 
characteristics in pediatric melanoma patients show no 
evident differences to adult melanoma cases; thus, the 
literature suggests the same clinical approach as in 
adults should be used [12]. 
 
In conclusion, reported two cases of pediatric 
patients with clinically localized melanomas who were 
referred for radicalization of surgery with safety 
margins together with sentinel lymph node biopsy, 
followed by an interferon therapy in case of confirmed 
metastasis or no further therapy in case of negative 
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